Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02356900 · ClinicalTrials.gov registry record · Phase 2
Hyperbaric VO2max Study
A Phase 2 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT02356900: Clinical Trial Phase 2 study, sponsored by Duke University.
NCT02356900 is a Phase 2 study that was terminated before completion, run by Duke University. The registered enrollment target is 25 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02356900, a Phase 2 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study seeks to examine the effectiveness of training while in a hyperoxic-hyperbaric environment for exercise performance at altitude. Subjects will complete a short, high-intensity interval training (HIT) program inside the hyperbaric chamber.Before and after this training phase, all subjects will be tested for maximum aerobic capacity at a simulated high altitude of 15,000ft in a hypobaric chamber, as well as for molecular markers of mitochondrial oxidative capacity in a skeletal muscle biopsy. A group of individuals of similar characteristics completing this training program in a normoxic-normobaric environment will serve as a control.
Primary Outcome
Graded exercise test to exhaustion at simulated 15000 ft altitude
Interventions
- DRUG Oxygen
- PROCEDURE Hyperoxic hyperbaric interval exercise training
- PROCEDURE Normoxic, normobaric, interval exercise training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-05 |
| Phase | Phase 2 |
Why NCT02356900 stopped before completion
NCT02356900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 3 interventions - of which Oxygen is the first listed.
NCT02356900 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02356900 about?
NCT02356900 is a clinical study titled "Hyperbaric VO2max Study". This study seeks to examine the effectiveness of training while in a hyperoxic-hyperbaric environment for exercise performance at altitude. Subjects will complete a short, high-intensity interval training (HIT) program inside the hyperbaric chamber.Before and after this training phase, all subjects ...
What is the current status of trial NCT02356900?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2015-02. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02356900?
The interventions under investigation include: Oxygen (DRUG), Hyperoxic hyperbaric interval exercise training (PROCEDURE), Normoxic, normobaric, interval exercise training (PROCEDURE).
Who is sponsoring clinical trial NCT02356900?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02356900's enrollment target sits among peer trials
25 1719th of 2000 higher than 245 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia